DKBmed Radio

How burdensome is spasticity for patients with MS? What’s the approach to treatment, and how effective is it? What do patients and clinicians need to know about cannabis-based therapies?  These are the key questions Program Director Dr. Michael Kornberg from the Johns Hopkins School of Medicine discusses with guest MS spasticity experts in this second part of this eMultipleSclerosis Review Special Edition. Take our post-test to claim CME credits.To read a companion newsletter click here.

Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them for tomorrow. That’s the focus of this Special HBV Edition of eViralHepatitis Review.The first part of this program presented an evidence-based expert commentary by eViralHepatitis Review Program Director Dr. Mark Sulkowski — Professor of Medicine at Johns Hopkins and Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. This second part is an interview providing more in-depth discussions between Dr. Sulkowski and three of medicine’s top CHB experts. Take our post-test to claim CME credits.To read a companion newsletter click here.

In her Expert Commentary, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer data describing the modifiable and nonmodifiable risk factors for developing MS and/or increasing the rate of disease progression and disability.Join us for this podcast as Dr. Ward explains how these findings can affect clinical practice to improve overall care of individuals with MS. Take our post-test to claim CME credits.Read this podcast's companion newsletter here.

Dr. Paul Auwaerter discusses XBB and XBB.1.5 subvariants and the respiratory virus season. Topics: *Why XBB and XBB.1.5 subvariants are more transmissible than other subvariants, but less virulent *Effect of Paxlovid on hospitalization and mortality *Summary of the flu and RSV season *Deciding when to treat a COVID-19 patient Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/1-26-23-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Clinical Director, Division of Infectious Diseases, Sherrilyn and Ken Fisher Professor of Medicine, Fisher Center for Environmental Infectious Diseases, Johns Hopkins University School of Medicine 

Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their mental health? What effect does it have on their engagement in HIV care? What do health care providers need to change to minimize stigma in their practices? These are some of the questions advanced practice nurse Dallas Ducar, CEO of Transhealth, discusses in this issue of eHIV Review. Take our post-test to claim CME credits.To read a companion newsletter click here.

Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator treatments — HEMT — changed that situation? That’s the focus of this eCysticFibrosis Review Special Edition: CF and Nutrition and HEMT.  The first part of this program presented an evidence-based Expert Commentary on the current status of weight gain, obesity, and nutrition among people with CF by guest author Katie McDonald, PhD, MS, RDN, CSP, a clinical dietitian at Primary Children's Medical Center in Salt Lake City. The second part is a podcast interview, providing further in-depth discussions between Katie McDonald and three top CF nutrition experts.  Take our post-test to claim CME credits.Read this podcast's companion newsletter here.

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?Which drug combinations are right? Where does the balance between side effects and adherence lie?These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.Take our post-test to claim CME credits.To read a companion newsletter click here.

How aware are clinicians that MS should no longer be considered a “White people only” disease? What roles have race and ethnicity been shown to play in MS disease severity and disability progression? What do health care professionals need to know to provide the most effective care for all their patients?Join Dr. Yujie Wang from the University of Washington and Dr. Kimystian Harrison, a post doctoral fellow at Johns Hopkins University, as they explore these and other questions in this eMultipleSclerosis Review podcast.Take our post-test to claim CME credits.To read a companion newsletter click here.